Found 11 results
Author Title [ Type(Desc)] Year
Filters: Author is Ho, M  [Clear All Filters]
Journal Article
C. Schmidt, Smith, C., Barin, B., Bakhtyari, A., Bart, P. A., Bekker, L. G., Chomba, E., Clumeck, N., Ho, D., Hoosen, A., Jaoko, W., Kaleebu, P., Karita, E., Keefer, M. C., Lunzen, J. V., McMichael, A., Mehendale, S., Peters, B., Ramanathan, V. D., Robinson, A., Rockstroh, J., Vardas, E., Vets, E., Weber, J., Graham, B. S., Than, S., Excler, J. L., Kochhar, S., Ho, M., Heald, A., and Fast, P. E., Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-638, 2012.
R. McDonald, Smith, J., Ho, M., Lindblad, R., Ikle, D., Grimm, P., Wyatt, R., Arar, M., Liereman, D., Bridges, N., and Harmon, W., Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids, Am J Transplant, vol. 8, pp. 984-989, 2008.
M. A. Baum, Ho, M., Stablein, D., and , North American Pediatric Renal Transplant Cooperative Study. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis, Pediatr Transplantation, vol. 6, pp. 488-92, 2002.
S. Vasan, Schlesinger, S., Chen, Z., Hurley, A., Lombardo, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Boente-Carrera, M., Schmidt, C., Fang, Q., Ba, L., Huang, Y., Zaharatos, G., Gardiner, D., Caskey, M., Seamons, L., and Ho, M., Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 Clade B'/C Candidate Vaccine, PLOS One, vol. 5, p. e8816, 2010.
S. Vasan, Schlesinger, S., Huang, Y., Hurley, A., Lombardo, A., Chen, Z., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Schmidt, C., Song, Y., Seamons, L., Dally, L., Ho, M., Smith, C., Markowitz, M., Cox, J., Gill, D., and Gilmour, J., Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine, PLoS ONE, vol. 5, p. e8617, 2010.
W. Harmon, Meyers, K., Ingelfinger, J., McDonald, R., McIntosh, M., Ho, M., Spaneas, L., Palmer, J., Hawk, M., Geehan, C., Tinckam, K., Hancock, W., and Sayegh, M., Safety and Efficacy of a Calcineurin-Inhibitor Avoidance Regimen in Pediatric Renal Transplantation, J Am Soc Nephrol, vol. 17, pp. 1735-1745, 2006.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
A. M. Neu, Ho, M., Furth, S. L., Fine, R. N., and Fivush, B. A., Tacrolimus vs. Cyclosporine as Primary Immunosuppression in Pediatric Renal Transplant Patients: a naprtcs study, 2002.